Shenzhen Wingor Biotechnology Co., Ltd.
Clinical trials sponsored by Shenzhen Wingor Biotechnology Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cord stem cells infused for stroke: a new hope? Results expected May 2027 (estimated)
-
Can umbilical cord stem cells revive failing ovaries?
Disease control Recruiting nowThis trial is testing whether infusions of stem cells from human umbilical cord tissue can safely help women with premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40, leading to irregular periods and fertility challenges. The study invo…
Phase 1/2 • Sponsor: Shenzhen Wingor Biotechnology Co., Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Cord stem cells infused for stroke: a new hope?
Disease control Recruiting nowThis study tests whether stem cells from donated umbilical cords can improve recovery after a recent stroke. About 60 adults who had a stroke within the last 72 hours will receive either one or two infusions of these cells or a placebo. The goal is to see if the treatment helps r…
Phase 2 • Sponsor: Shenzhen Wingor Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC